Chronic obstructive pulmonary disease and bronchiectasias.;EPOC y bronquiectasias

Archivos de Bronconeumologia

Volumn 46, Issue SUPPL. 3, 2010, Pages 11-17

  García, Miguel Ángel Martínez ^a   Cataluña, Juan José Soler ^a  

^a HOSPITAL GENERAL DE REQUENA   (Spain)

Author keywords

Bronchial colonization; Bronchial infection; Bronchiectasias; Chronic obstructive pulmonary disease; Exacerbation; Potentially pathogenic microorganisms; Pseudomonas aeruginosa

Indexed keywords

ALPHA 1 ANTITRYPSIN; INTERLEUKIN 6; INTERLEUKIN 8; VASCULAR CELL ADHESION MOLECULE 1;

ANTIBIOTIC RESISTANCE; ARTICLE; BRONCHIECTASIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; MICROBIAL COLONIZATION; MORTALITY; PATHOPHYSIOLOGY; PREVALENCE; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR;

BRONCHIECTASIS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 77953877303     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(10)70021-1     Document Type: Article

References (62)

1. Estévez J.I., Martínez-González M.A., Seguí-Gómez M. Epidemiología aplicada 2004, Ariel Ciencias Médicas, Barcelona.
2. Sobradillo V., Miravitlles M., Jiménez C.A., Gabriel R., Viejo J.L., Masa J.F., et al. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol 1999, 35:159-166.
3. Miravitlles M., Soriano J.B., García-Río F., Muñoz L., Duran-Tauleria E., Sanchez G., et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009, 64:863-868.
4. Martínez-García M.A. Bronquiectasias: ¿todavía una enfermedad huérfana?. Arch Bronconeumol 2005, 41:407-409.
5. Weycker D., Edelsberg J., Oster G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med 2005, 12:205-209.
6. Nicotra M.B., Rivera M., Dale A.M., Shepherd R., Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995, 108:955-961.
7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. [Consultado 3/12/2009]. Disponible en: http://www.goldcopd.com/Guidelineitem.
8. Stockley R.A. Neutrophils and the patogénesis of COPD. Chest 2002, 121:151s-155s.
9. Fuschillo S., De Felice A., Balzano G. Mucosal inflammation in idiopathic bronchiectasis: celllar and molecular mechanisms. Eur Respir J 2008, 31:396-406.
10. Cole P.J. Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl 1986, 147:6-15.
11. O'Brien C.O., Guest P.J., Hill S.L., Stockley R.A. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000, 55:635-642.
12. Patel I.S., Vlahos I., Wilkinson T.M.A., Lloyd-Owen S.J., Donaldson G.C., Wilks M., et al. Bronchiectasis, exacerbations indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400-407.
13. Donat Y., Martínez-García M.A., Soler-Cataluña J.J., Perpiná-Tordera M., Román-Sánchez P. Prevalencia de bronquiectasias y su impacto clínico-funcional en pacientes con enfermedad pulmonar obstructiva crónica moderado-grave. Arch Bronconeumol 2008, 44:60.
14. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008, 14:595-599.
15. O'Donnell A.E. Bronchiectasis. Chest 2008, 134:815-823.
16. Naidich D.P., McCauley D.I., Khouri N.F., Stitik P.P., Siegalman S.S. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982, 6:437-444.
17. Olveira C, Doña E, De la Cruz JL. Diagnóstico por la imagen en las bronquiectasias. En: Martínez-García MA. Bronquiectasias no debidas a fibrosis quística. Neumología y Salud. SL ed; 2008.
18. O'Donnell R., Breen D., Wilson S., Djukanovic R. Inflammatory cells in the airways in COPD. Thorax 2006, 61:448-454.
19. Zheng L., Tipoe G., Lam W.K., Ho J.C., Shum I., Ooi G.C., et al. Endothelin-1 in stable bronchiectasis. Eur Respir J 2000, 16:146-149.
20. Chan S.C., Shum D.K., Ip M.S. Sputum sol neutrophils elastase activity in bronchiectasis: differential modulation by syndecam-1. Am Respir J Crit Care Med 2003, 168:192-198.
21. Angrill J., Agusti C., De Celis R., Filella X., Raño A., Elena M., et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001, 164:1628-1632.
22. Angrill J., Agusti C., De Celis R., Ramo A., Gonzalez J., Sollé T., et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002, 57:15-19.
23. Zalacaín R., Sobradillo V., Amilibia J., Barrón J., Achótegui V., Pijoan J.I., et al. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999, 13:343-348.
24. Monsó E., Rosell A., Bonet G., Manterola J., Cardona P.J., Ruiz J., et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 1999, 13:338-342.
25. Soler N., Ewig S., Torres A., Filella X., González J., Xaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999, 14:1015-1022.
26. Lapa e Silva J.R., Jones J.A.H., Cole P.J., Poulter L.W. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989, 44:668-673.
27. Gaga M., Bentley A.M., Humbert M., Barkans J., O'Brien F., Wathen C.G., et al. Increases in CD4 + T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998, 53:685-691.
28. Murphy M.B., Reen D.J., Fitzgerald M.X. Atopy, inmunological changes, and respiratory function in bronchiectasis. Thorax 1984, 39:179-184.
29. Cantón R., Cobos N., De Gracia J., Baquero F., Honorato J., Gartner S., et al. Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística. Arch Bronconeumol 2005, 41:1-25.
30. Woodhead M., Blasi F., Ewig S., Huchon G., Leven M., Ortqvist A., et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005, 26:1138-1180.
31. Martínez-García M.A., Perpiñá-Tordera M., Román-Sánchez P., Soriano J.B. Factors associated with lung function decline in patients with non-cystic fibrosis bronchiectasis. Chest 2007, 132:1565-1572.
32. Evans S.A., Turner S.M., Bosch B.J., Hardy C.C., Woodhead M.A. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996, 9:1601-1604.
33. Davies G., Wells A.U., Doffman S., Watanabe S., Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J 2006, 28:974-979.
34. Martínez-García M.A., Perpiñá M., Román P., Soler J.J. Quality of life determinants in patients with clinically stable bronchiectasis. Chest 2005, 128:739-745.
35. Miszkiel K.A., Wells A.U., Rubens M.B., Cole P.J., Hansell D.M. Effects of airway infection by Pseudomonas aeruginosa: a computed tomography study. Thorax 1997, 52:260-264.
36. King P.T., Holdsworth S.R., Freezer N.J., Villanueva E., Colmes P.W. Microbiologic follow-up study in adult bronchiectasis. Respir Med 2007, 101:1633-1638.
37. Loebinger M.R., Wells A.U., Hansell D.M., Chinyanganya N., Devaraj A., Meister M., et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009, 34:843-849.
38. Rosell A., Monsó E., Soler N., Torres F., Angrill J., Riise G., et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005, 165:891-897.
39. Murphy T.F., Brauer A.L., Eschberger K., Lobbins P., Grove L., Cai X., et al. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:853-860.
40. Miravitlles M., Espinosa C., Fernández-laso E., Marts J.A., Maldonado J.A., Gallego M. Relationship between bactrial flora in sputum and functional impairment in patines with acute exacerbations of COPD. Chest 1999, 116:40-46.
41. Sethi S., Evans N., Brydon R.N., Grant J.B., Murphy T.F. New strains of bacterial and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465-471.
42. García-Vidal C., Almagro P., Romani V., Rodríguez-Carballeira M., Cuchi E., Canales L., et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbations: a prospective study. Eur Respir J 2009, 34:1072-1078.
43. Eller J., Ede A., Schaberg T., Niederman M.S., Mauch H., Lode H. Infective exacerbations of chronic bronchitis. Chest 1998, 113:1542-1548.
44. Soler N., Torres A., Ewig S., González J., Celis R., El-Ebiary M., et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998, 157:1498-1505.
45. Lode H., Allewelt M., Balk S., De Roux A., Mauch H., Niederman M., et al. A prediction model for bacterial etiology in acute exacerbations of COPD. Infection 2007, 35:143-149.
46. Murphy T.F. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease. Curr Opin Pulm Med 2009, 15:138-142.
47. Hill A.T., Campbell E.J., Hill S.T., Bayley D.L., Stockley R.A. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000, 109:288-295.
48. Vendrell M., De Gracia J., Olveira C., Martínez-García M.A., Girón R., Máiz L., et al. Normativa sobre el diagnóstico y tratamiento de las bronquiectasias. Arch Bronconeumol 2008, 44:629-640.
49. Pasteur M.C., Helliwell S.M., Houghton S.J., Webb S.C., Foweraker J.E., Coulden R.A., et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000, 162:1277-1284.
50. Parr D.G., Guest P.G., Reynolds J.H., Dowson L.J., Stockley R.A. Prevalence and impact of bronchiectasis in alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med 2007, 176:1215-1221.
51. Cuvelier A., Muir J.F., Hellot M.F., Benhamou D., Martin J.P., Bénichou J., et al. Distribution of alpha 1 antitrypsin alleles in patients with bronchiectasis. Chest 2000, 117:415-419.
52. Soler-Cataluña J.J., Martínez-García M.A., Román Sánchez P., Salcedo E., Navarro M., Ochando R. Severe acute exacerbations and mortality in patients with obstructive pulmonary disease. Thorax 2005, 60:925-931.
53. Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequancy and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
54. Vestbo J., Prescott E., Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996, 153:1530-1535.
55. Prescott E., Lange P., Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995, 8:1333-1338.
56. Bhowmik A., Seemungal T.A.R., Sapsford R.J., Wedzicha J.A. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000, 55:114-120.
57. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respire Crit Care Med 2003, 167:1090-1095.
58. Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacterial important?. Eur Respir J 2002, 20(Suppl 36):9s-19s.
59. Sethi S., Maloney J., Grove L., Wrona C., Berenson C.S. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:991-998.
60. Banerjee D., Khair O.A., Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 2004, 23:685-691.
61. Patel I.S., Seemungal T.A.R., Wilks M., Lloyd-Owen S.J., Donaldson G.C., Wedzicha J.A. Relationship between bacterial colonisation and the frequency, caracter, and severity of COPD exacerbations. Thorax 2002, 57:759-764.
62. Hoffman E.A., Simon B.A., McLennan G. A structural and functional assessment of the lung via multidetector-row computed tomography. Proc Am Thorac Soc 2006, 3:519-534.